These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35775414)

  • 1. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review.
    Ramos-Herrada RM; Arriola-Guillén LE; Atoche-Socola KJ; Bellini-Pereira SA; Castillo AA
    Dent Med Probl; 2022; 59(2):271-280. PubMed ID: 35775414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials.
    Leonardi G; Alito A; Portaro S; Di Matteo B; Respizzi S; Kon E; Massazza G; Sconza C
    Eur J Pain; 2024 Mar; 28(3):369-381. PubMed ID: 37950343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
    Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
    Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction.
    Awan KH; Patil S; Alamir AWH; Maddur N; Arakeri G; Carrozzo M; Brennan PA
    J Oral Pathol Med; 2019 Mar; 48(3):192-200. PubMed ID: 30604895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical review of the use of botulinum toxin in orofacial pain disorders.
    Clark GT; Stiles A; Lockerman LZ; Gross SG
    Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
    Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
    J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
    Ho KY; Tan KH
    Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manual Therapy in the Treatment of Myofascial Pain Related to Temporomandibular Disorders: A Systematic Review.
    de Melo LA; Bezerra de Medeiros AK; Campos MFTP; Bastos Machado de Resende CM; Barbosa GAS; de Almeida EO
    J Oral Facial Pain Headache; 2020 Spring; 34(2):141-148. PubMed ID: 32255579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
    Delcanho R; Val M; Guarda Nardini L; Manfredini D
    J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
    Meister MR; Brubaker A; Sutcliffe S; Lowder JL
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e152-e160. PubMed ID: 32301801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin treatment of myofascial pain: a critical review of the literature.
    Gerwin R
    Curr Pain Headache Rep; 2012 Oct; 16(5):413-22. PubMed ID: 22777564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin therapy for myofascial pain disorders.
    Lang AM
    Curr Pain Headache Rep; 2002 Oct; 6(5):355-60. PubMed ID: 12207848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.